NVSNovartis AG
Healthcare · Drug Manufacturers - GeneralNYSEStockMkt cap $261.7B
Disclosed trades
42
0 in 30d · 1 in 90d
Politicians
13
Last trade Aug 27, 2026
Buys
17
$252K at range midpoints
Sells
25
$507.5K at range midpoints
Closing price · 365 days
Nov 6, 2025 – Nov 5, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
6 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| DDonald S. Beyer, Jr. | House · VA-08 | 13 | 6 | 7 | $48K | $56K | Feb 28, 2022 | $404 |
| RLisa C. McClain | House · MI-09 | 10 | 5 | 5 | $40K | $40K | Oct 31, 2025 | $145 |
| DAlan S. Lowenthal | House · CA-47 | 3 | 0 | 3 | $0 | $48.5K | Nov 23, 2020 | — |
| DDaniel S. Goldman | House · NY-10 | 3 | 1 | 2 | $75K | $107.5K | Jul 10, 2023 | $6.2K |
| RKevin Hern | House · OK-01 | 3 | 1 | 2 | $8K | $40.5K | Aug 27, 2026 | — |
| RAlan Armstrong | Senate · OK | 2 | 2 | 0 | $40.5K | $0 | Mar 31, 2026 | $43.5K |
| DSheldon Whitehouse | Senate · RI | 2 | 1 | 1 | $32.5K | $8K | Apr 9, 2024 | $37.3K |
| RBill Cassidy | Senate · LA | 1 | 0 | 1 | $0 | $8K | Apr 5, 2019 | — |
| DGeorge Whitesides | House · CA-27 | 1 | 0 | 1 | $0 | $175K | Mar 24, 2025 | — |
| RGreg Gianforte | House · MT-00 | 1 | 1 | 0 | $8K | $0 | Mar 18, 2020 | $17.3K |
| RJohn H. Rutherford | House · FL-05 | 1 | 0 | 1 | $0 | $8K | Mar 16, 2022 | — |
| DMikie Sherrill | House · NJ-11 | 1 | 0 | 1 | $0 | $8K | Feb 20, 2020 | — |
| RShelley Moore Capito | Senate · WV | 1 | 0 | 1 | $0 | $8K | Dec 15, 2021 | — |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| RKevin Hern | NVS | Novartis AG Common Stock (NVS) | Sell | Self | $15,001 - $50,000 | -16.3% | Aug 27, 2026 | Sep 25, 202629d | Filing |
| RAlan Armstrong | NVS | Novartis AG Common Stock | Buy | Self | $1,001 - $15,000 | +7.3% | Mar 31, 2026 | Jul 21, 2026112d | Filing |
| RAlan Armstrong | NVS | Novartis AG Common Stock | Buy | Self | $15,001 - $50,000 | +7.3% | Mar 30, 2026 | Jul 21, 2026113d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Sell | Spouse | $1,001 - $15,000 | -16.0% | Oct 31, 2025 | Nov 21, 202521d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Sell | Spouse | $1,001 - $15,000 | -16.0% | Oct 30, 2025 | Nov 21, 202522d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Buy | Spouse | $1,001 - $15,000 | +16.0% | Oct 30, 2025 | Nov 21, 202522d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Partial | Spouse | $1,001 - $15,000 | -13.4% | Sep 25, 2025 | Oct 22, 202527d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Buy | Spouse | $1,001 - $15,000 | +13.4% | Sep 11, 2025 | Oct 22, 202541d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Partial | Spouse | $1,001 - $15,000 | -19.9% | Jul 22, 2025 | Aug 13, 202522d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Buy | Spouse | $1,001 - $15,000 | +19.9% | Jun 17, 2025 | Aug 13, 202557d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Buy | Spouse | $1,001 - $15,000 | +19.9% | Jun 11, 2025 | Aug 13, 202563d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Partial | Spouse | $1,001 - $15,000 | -19.9% | Jun 10, 2025 | Aug 13, 202564d | Filing |
| RLisa C. McClain | NVS | Novartis AG Common Stock (NVS) | Buy | Spouse | $1,001 - $15,000 | +19.9% | Jun 9, 2025 | Aug 13, 202565d | Filing |
| DGeorge Whitesides | NVS | Novartis AG Common Stock (NVS) | Sell | Self | $100,001 - $250,000 | -10.1% | Mar 24, 2025 | Apr 23, 202530d | Filing |
| DSheldon Whitehouse | NVS | Novartis Ag ADR | Partial | Self | $1,001 - $15,000 | -19.2% | Apr 9, 2024 | May 20, 202441d | Filing |
| DSheldon Whitehouse | NVS | Novartis Ag ADR | Buy | Self | $15,001 - $50,000 | -0.3% | Sep 20, 2023 | Oct 17, 202327d | Filing |
| DDaniel S. Goldman | NVS | Novartis AG (NVS) | Sell | Self | $50,001 - $100,000 | +6.9% | Jul 10, 2023 | Aug 13, 202334d | Filing |
| DDaniel S. Goldman | NVS | Novartis AG (NVS) | Buy | Self | $50,001 - $100,000 | -11.8% | Mar 31, 2023 | Apr 17, 202317d | Filing |
| DDaniel S. Goldman | NVS | Novartis AG (NVS) | Partial | Self | $15,001 - $50,000 | -7.9% | Feb 27, 2023 | Mar 20, 202321d | Filing |
| RKevin Hern | NVS | Novartis AG (NVS) | Sell | Joint | $1,001 - $15,000 | -7.3% | Jan 31, 2023 | Feb 14, 202314d | Filing |
| RJohn H. Rutherford | NVS | Novartis AG (NVS) | Sell | Self | $1,001 - $15,000 | -12.1% | Mar 16, 2022 | Apr 19, 202234d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Sell | Joint | $1,001 - $15,000 | -19.8% | Feb 28, 2022 | Mar 3, 20223d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | +21.8% | Jan 27, 2022 | Feb 1, 20225d | Filing |
| RShelley Moore Capito | NVS | Novartis AG Common Stock | Sell | Spouse | $1,001 - $15,000 | -18.7% | Dec 15, 2021 | Jan 21, 202237d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Sell | Joint | $1,001 - $15,000 | -30.8% | Dec 22, 2021 | Jan 1, 202210d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Sell | Joint | $1,001 - $15,000 | -28.7% | Sep 17, 2021 | Oct 1, 202114d | Filing |
| DAlan S. Lowenthal | NVS | Novartis Ag (NVS) | Sell | Spouse | $1,001 - $15,000 | +20.5% | Nov 23, 2020 | Dec 3, 202010d | Filing |
| DAlan S. Lowenthal | NVS | Novartis Ag (NVS) | Sell | Spouse | $1,001 - $15,000 | +20.5% | Nov 23, 2020 | Dec 3, 202010d | Filing |
| DAlan S. Lowenthal | NVS | Novartis Ag (NVS) | Sell | Spouse | $15,001 - $50,000 | +20.5% | Nov 23, 2020 | Dec 3, 202010d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | -21.8% | Nov 17, 2020 | Dec 1, 202014d | Filing |
| RBill Cassidy | NVS | Novartis AG | SellAmended | Spouse | $1,001 - $15,000 | — | Apr 5, 2019 | Nov 18, 2020593d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis AG (NVS) | Sell | Joint | $1,001 - $15,000 | +17.0% | Oct 5, 2020 | Nov 5, 202031d | Filing |
| RKevin Hern | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | -28.8% | Jul 27, 2020 | Aug 15, 202019d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Sell | Joint | $1,001 - $15,000 | +21.9% | Jul 14, 2020 | Aug 9, 202026d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Sell | Joint | $1,001 - $15,000 | +53.1% | May 7, 2020 | May 31, 202024d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Sell | Joint | $1,001 - $15,000 | +53.1% | May 4, 2020 | May 31, 202027d | Filing |
| RGreg Gianforte | NVS | Novartis aG (NVS) | Buy | Joint | $1,001 - $15,000 | -83.7% | Mar 18, 2020 | Apr 7, 202020d | Filing |
| DMikie Sherrill | NVS | Novartis ag (NVS) | Sell | Self | $1,001 - $15,000 | +87.9% | Feb 20, 2020 | Apr 5, 202045d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | -47.6% | Feb 14, 2020 | Feb 22, 20208d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | -47.6% | Jan 27, 2020 | Feb 22, 202026d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | -47.6% | Jan 14, 2020 | Feb 22, 202039d | Filing |
| DDonald S. Beyer, Jr. | NVS | Novartis Ag (NVS) | Buy | Joint | $1,001 - $15,000 | — | Dec 26, 2019 | Jan 2, 20207d | Filing |
Unusual activity Estimated
- 43Committee overlapPublic Sep 25, 2026 · traded Aug 27, 2026
Rep. Kevin Hern sold $15,001–$50,000 of NVS while sitting on House Ways and Means
Details
- Committee
- House Committee on Ways and Means
- Leadership seat
- No
- Sector
- Healthcare
- Disclosed range
- $15,001 - $50,000
- Traded
- Aug 27, 2026
- Filed
- Sep 25, 2026
- Public from
- Sep 25, 2026
- Method version
- 2026-11-03
- 43Committee overlapPublic Jul 21, 2026 · traded Mar 30, 2026
Sen. Alan Armstrong bought $15,001–$50,000 of NVS while sitting on Senate Health
Details
- Committee
- Senate Committee on Health, Education, Labor, and Pensions
- Leadership seat
- No
- Sector
- Healthcare
- Disclosed range
- $15,001 - $50,000
- Traded
- Mar 30, 2026
- Filed
- Jul 21, 2026
- Public from
- Jul 21, 2026
- Method version
- 2026-11-03
- 33First-time tickerPublic Apr 23, 2025 · traded Mar 24, 2025
First-ever NVS trade for Rep. George Whitesides: $100K–$250K sale
Details
- Politician
- George Whitesides
- Ticker
- NVS
- Asset
- Novartis AG Common Stock (NVS)
- Tx type
- sell
- Traded
- Mar 24, 2025
- Filed
- Apr 23, 2025
- Amount low
- $100K
- Amount high
- $250K
- Range midpoint (estimate)
- $175K
- Disclosed range
- $100,001 - $250,000
- Reporting lag days
- 30
- Owner type
- self
- Is whale
- No
- Public from
- Apr 23, 2025
- Method version
- 2026-11-03